In the event of non-compliance with the legislative and regulatory provisions or the conditions of the authorisation, the suspension, which may not exceed one year, and the withdrawal of the authorisation are ordered by the Director General of the Agence nationale de sécurité du médicament et des produits de santé.
These decisions may concern all or part of the authorised activity and may only be taken after the party concerned has been informed of the nature of the breaches observed and given formal notice to put an end to them within a specified period.
Suspension and withdrawal decisions are made public by the Director General of the Agence nationale de sécurité du médicament et des produits de santé.
The Director General of the Agence nationale de sécurité du médicament et des produits de santé will send the Director General of the Agence de la biomédecine and the Directors of the Regional Health Agencies concerned the suspension or withdrawal measures he has ordered.